ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCI, Private Groups, Promote Mammograms To Blacks, Hispanics

April 25, 1992

In Brief: Data Availability From Cancer Survey Presents Problems – Who Gets It first, Confidentiality

August 30, 1974

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021

In Brief: Ross, Harvey To Lead Cancer Center Group; NCI Director In Office By Aug. 1, Varmus Says

May 19, 1995

DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women

October 26, 1990

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009